Latarcin-5

General Information


DRACP ID  DRACP00227

Peptide Name   Latarcin-5

Sequence  GFFGKMKEYFKKFGASFKRRFANLKKRL

Sequence Length  28

UniProt ID  Not available

PubChem CID  Not available

Origin  Lachesana tarabaevi

Type  Native peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
K562 Blast phase chronic myelogenous leukemia, BCR-ABL1 positive; Chronic myeloid leukemia Leukemia EC50=12 µM Hoechst 33342 and PI assay 3h 1

Hemolytic Activity  Rabbit erythrocytes: 20% Hemolysis=40 µM; Human erythrocytes: 50% Hemolysis=12 µM; 27% Hemolysis=256 µg/ml

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial; Antifungal



Structure Information


PDB ID  Not available

Predicted Structure  DRACP00227

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C164H253N45O34S

Absent amino acids  CDHIPQTVW

Common amino acids  K

Mass  391290

Pl  11.87

Basic residues  10

Acidic residues  1

Hydrophobic residues  10

Net charge  9

Boman Index  -6409

Hydrophobicity  -75.71

Aliphatic Index  35

Half Life 
  Mammalian: 30 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  1490

Absorbance 280nm  55.19

Polar residues  6

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 19563807

Title  N-terminal amphipathic helix as a trigger of hemolytic activity in antimicrobial peptides: a case study in latarcins

Doi 10.1016/j.febslet.2009.06.044

Year  2009

Literature 2

Pubmed ID 16735513

Title  Latarcins, antimicrobial and cytolytic peptides from the venom of the spider Lachesana tarabaevi (Zodariidae) that exemplify biomolecular diversity

Doi 10.1074/jbc.M602168200

Year  2006

Literature 3

Pubmed ID 34576320

Title  Membrane Interactions of Latarcins: Antimicrobial Peptides from Spider Venom

Doi 10.3390/ijms221810156

Year  2021

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.